[metrics]
length=664

[prompt]
You are in the role of an abstractor who will analyze eligibility criteria for a clinical trial and represent the information as a list of individual criteria in a tabular format that will contain the following columns: 
Type: listing whether criterion is an Exclusion or Inclusion criterion
Original Text: the original text of the criterion
Disease/Condition: If the criterion contains a disease or condition name it by its canonical name
Procedure: If the criterion contains a therapeutic procedure name it by its canonical name
Drug:  If the criterion contains a therapeutic drug name it by its canonical name
Biomarker:  If the criterion contains a biomarker name it by its canonical name
Computable Rule: Translate the criteria into a logical expression that could be interpreted programmatically
    Inclusion Criteria
•	The participant is >= 18 years old
•	Absolute neutrophil count >= 1,000/ul
•	Platelets >= 75,000/ul
•	Hemoglobin >= 9 g/dL
•	Total bilirubin =< 1.5 mg/dL (upper limit of normal) except subject with documented Gilbert's syndrome (=< 5 x upper limit of normal [ULN]) or liver metastasis, who must have a baseline total bilirubin =< 3.0 mg/dL
•	Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT])/alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< 2.5 x institutional ULN OR =< 5.0 x institutional ULN for patients with documented liver metastases

Exclusion Criteria
•	The subject has an uncontrolled intercurrent illness, including, but not limited to, ongoing or active infection, uncontrolled hypertension, unstable angina pectoris, uncontrolled cardiac arrhythmia, congestive heart failure-New York Heart Association class III or IV, active ischemic heart disease, myocardial infarction within the previous six months, uncontrolled diabetes mellitus (DM), gastric or duodenal ulceration diagnosed within the previous 6 months, chronic liver or renal disease, or severe malnutrition. If a participant has controlled DM but is unable to monitor blood sugars at home, they will be excluded from the trial
•	The subject is pregnant or breast-feeding
•	No active, second potentially life-threatening cancer
•	Has had major surgery within 21 days before initiation of protocol therapy
•	Active infection requiring IV antibiotics at the time of protocol therapy initiation